Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer

被引:23
|
作者
Lee, Joo Ho [1 ,2 ]
Kim, Dae Yong [1 ]
Kim, Sun Young [1 ]
Park, Ji Won [1 ]
Choi, Hyo Seong [1 ]
Oh, Jae Hwan [1 ]
Chang, Hee Jin [1 ]
Kim, Tae Hyun [1 ]
Park, Suk Won [3 ]
机构
[1] Natl Canc Ctr, Res Inst & Hosp, Ctr Colorectal Canc, Goyang, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea
[3] Chung Ang Univ, Coll Med, Dept Radiat Oncol, Seoul 156756, South Korea
来源
RADIATION ONCOLOGY | 2011年 / 6卷
关键词
CURATIVE RESECTION; PELVIC RECURRENCE; RADICAL RESECTION; PROGNOSTIC-FACTOR; SURGERY; EXPERIENCE; MANAGEMENT; REIRRADIATION; RADIOTHERAPY; IRRADIATION;
D O I
10.1186/1748-717X-6-51
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: To assess the clinical outcome of chemoradiotherapy with or without surgery for locally recurrent rectal cancer (LRRC) and to find useful and significant prognostic factors for a clinical situation. Methods: Between January 2001 and February 2009, 67 LRRC patients, who entered into concurrent chemoradiotherapy with or without surgery, were reviewed retrospectively. Of the 67 patients, 45 were treated with chemoradiotherapy plus surgery, and the remaining 22 were treated with chemoradiotherapy alone. The mean radiation doses (biologically equivalent dose in 2-Gy fractions) were 54.6 Gy and 66.5 Gy for the chemoradiotherapy with and without surgery groups, respectively. Results: The median survival duration of all patients was 59 months. Five-year overall (OS), relapse-free (RFS), locoregional relapse-free (LRFS), and distant metastasis-free survival (DMFS) were 48.9%, 31.6%, 66.4%, and 40.6%, respectively. A multivariate analysis demonstrated that the presence of symptoms was an independent prognostic factor influencing OS, RFS, LRFS, and DMFS. No statistically significant difference was found in OS (p = 0.181), RFS (p = 0.113), LRFS (p = 0.379), or DMFS (p = 0.335) when comparing clinical outcomes between the chemoradiotherapy with and without surgery groups. Conclusions: Chemoradiotherapy with or without surgery could be a potential option for an LRRC cure, and the symptoms related to LRRC were a significant prognostic factor predicting poor clinical outcome. The chemoradiotherapy scheme for LRRC patients should be adjusted to the possibility of resectability and risk of local failure to focus on local control.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Treatment of locally recurrent rectal cancer
    Garcia-Aguilar, J
    Cromwell, JW
    Marra, C
    Lee, SH
    Madoff, RD
    Rothenberger, DA
    DISEASES OF THE COLON & RECTUM, 2001, 44 (12) : 1743 - 1748
  • [32] Surgery for locally recurrent rectal cancer
    Boyle, KM
    Sagar, PM
    Chalmers, AG
    Sebag-Montefiore, D
    Cairns, A
    Eardley, I
    DISEASES OF THE COLON & RECTUM, 2005, 48 (05) : 929 - 937
  • [33] Treatment of Locally Recurrent Rectal Cancer
    Regan, Samuel N.
    Hendren, Samantha
    Krauss, John C.
    Crysler, Oxana V.
    Cuneo, Kyle C.
    CANCER JOURNAL, 2024, 30 (04): : 264 - 271
  • [34] Management of locally recurrent rectal cancer
    Davis, Bradley R.
    Schlosser, Kathryn A.
    SEMINARS IN COLON AND RECTAL SURGERY, 2019, 30 (02) : 85 - 88
  • [35] Management of locally recurrent rectal cancer
    Hureibi, Khalid
    EJSO, 2018, 44 (08): : 1281 - 1281
  • [36] Neoadjuvant Chemoradiotherapy in Locally Advanced and Locally Recurrent Colon Cancer
    Agas, R. A. F.
    Fahey, M.
    Gosavi, R. R.
    Kong, J. C. H.
    Tan, J.
    Chu, J.
    Leong, T.
    Warrier, S.
    Heriot, A.
    Ngan, S. Y.
    CLINICAL ONCOLOGY, 2025, 37
  • [37] CLINICAL OUTCOMES OF SALVAGE ENDOSCOPIC SUBMUCOSAL DISSECTION COMPARED TO SURGICAL RESECTION AFTER CHEMORADIOTHERAPY FOR LOCALLY ADVANCED RECTAL CANCER
    Leung, Galen
    Nishimura, Makoto
    Hingorani, Neha
    Lin, I. H. In
    Schattner, Mark A.
    GASTROINTESTINAL ENDOSCOPY, 2022, 95 (06) : AB201 - AB202
  • [38] Clinical Outcomes of Patients With Locally Advanced Rectal Cancer With Persistent Circumferential Resection Margin Invasion After Preoperative Chemoradiotherapy
    Kim, Chang Hyun
    Yeom, Seung-Seop
    Kwak, Hand-Duk
    Lee, Soo Young
    Ju, Jae Kyun
    Kim, Young Jin
    Kim, Hyeong Rok
    ANNALS OF COLOPROCTOLOGY, 2019, 35 (02) : 72 - 82
  • [39] Clinical outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision in locally advanced rectal cancer with mesorectal fascia involvement
    Ha Lee, Jeong
    Kim, Nalee
    Yu, Jeong Il
    Yoo, Gyu Sang
    Park, Hee Chul
    Lee, Woo-Yong
    Yun, Seong Hyeon
    Kim, Hee Cheol
    Cho, Yong Beom
    Huh, Jung Wook
    Park, Yoon Ah
    Shin, Jung Kyong
    Park, Joon Oh
    Kim, Seung Tae
    Park, Young Suk
    Lee, Jeeyun
    Kang, Won Ki
    RADIATION ONCOLOGY JOURNAL, 2024, 42 (02): : 130 - 138
  • [40] Long-term Clinical Outcomes of Nonoperative Management With Chemoradiotherapy for Locally Advanced Rectal Cancer in the Veterans Health Administration
    Spiegel, Daphna Y.
    Boyer, Matthew J.
    Hong, Julian C.
    Williams, Christina D.
    Kelley, Michael J.
    Moore, Harvey
    Salama, Joseph K.
    Palta, Manisha
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (03): : 565 - 573